Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group
- PMID: 1979160
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group
Abstract
The p53 gene has been implicated as a tumor suppressor gene with mutations found in common human cancers. We examined 51 early stage, primary, resected non-small cell lung cancer specimens using an RNAase protection assay and cDNA sequencing. Mutations changing the p53 coding sequence were found in 23/51 (45%) tumor specimens, but not in the corresponding normal lung, were distributed between codons 132 to 283, and included tumors with and without 17p allele loss. Fifteen of the 23 mutations lay in the predicted binding regions for SV40 large T antigen, and 14 were located in regions highly conserved between species. G to T transversions were a common result of p53 mutations in lung cancer compared to other cancers suggesting exposure to different mutagens. In univariate and multivariate analysis the presence of p53 mutations was associated with younger age and squamous histology. However, the presence of p53 mutations was not significantly associated with tumor stage, nodal status or sex and was found in all histologic types of lung cancer. We conclude that somatic mutations in the p53 gene play an important role in the pathogenesis of early stage non-small cell lung cancer.
Similar articles
-
p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking.Cancer Res. 1992 Feb 1;52(3):734-6. Cancer Res. 1992. PMID: 1310070
-
High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.Cancer Res. 1998 Jan 15;58(2):328-33. Cancer Res. 1998. PMID: 9443413
-
Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.Oncogene. 1998 May 14;16(19):2469-77. doi: 10.1038/sj.onc.1201776. Oncogene. 1998. PMID: 9627113
-
[Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].Rinsho Byori. 1996 Jan;44(1):32-41. Rinsho Byori. 1996. PMID: 8691638 Review. Japanese.
-
[p53 gene mutations in the human lung carcinoma].Nihon Rinsho. 1996 Feb;54(2):497-502. Nihon Rinsho. 1996. PMID: 8838104 Review. Japanese.
Cited by
-
Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines.Am J Pathol. 1991 Oct;139(4):839-45. Am J Pathol. 1991. PMID: 1656762 Free PMC article.
-
The relationship of p53 immunostaining to survival in carcinoma of the lung.Br J Cancer. 1992 Oct;66(4):735-8. doi: 10.1038/bjc.1992.348. Br J Cancer. 1992. PMID: 1329907 Free PMC article.
-
p53 expression in lymphatic malignancies.J Clin Pathol. 1992 Nov;45(11):1011-4. doi: 10.1136/jcp.45.11.1011. J Clin Pathol. 1992. PMID: 1452775 Free PMC article.
-
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.Br J Cancer. 2000 Aug;83(4):473-9. doi: 10.1054/bjoc.2000.1287. Br J Cancer. 2000. PMID: 10945494 Free PMC article.
-
A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10124-8. doi: 10.1073/pnas.88.22.10124. Proc Natl Acad Sci U S A. 1991. PMID: 1946433 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous